Drawing for CLAIRITY

USPTO serial 97212984

CLAIRITY

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
CHANG, ELIZABETH YI HSUAN
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with CLAIRITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Omar M. Wadhwa

Omar M. Wadhwa Cesari and McKenna, LLPOne Liberty SquareBoston, MA 02109United States

Goods and services

ClassDescriptionStatusFirst use
035Providing information, advice, and data on radiology practice managementACTIVE—
042Scientific and technological services, namely, scientific analysis of medical data and medical imaging in the field of breast health, including by means of artificial intelligence and deep learning in the fields of genomics, proteomics and radiomicsACTIVE—
044Medical analysis services relating to the treatment of persons; providing information, advice, and data on medical imaging relating to breast health; medical analysis of medical data and medical imaging in the field of breast health, including by means of artificial intelligence and deep learning in the fields of genomics, proteomics and radiomics; consulting services in the field of medicine, namely, the assessment and prediction of breast health risks, patient engagement in the nature of diagnosis and treatment, consultations relating to predicted clinical outcomesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 8, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 8, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 8, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 29, 2026EXT5SOU EXTENSION 5 FILED—
Apr 29, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 31, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 30, 2025EX4GSOU EXTENSION 4 GRANTED—
Oct 30, 2025EXT4SOU EXTENSION 4 FILED—
Oct 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 1, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 30, 2025EX3GSOU EXTENSION 3 GRANTED—
Apr 30, 2025EXT3SOU EXTENSION 3 FILED—
Apr 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 30, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 30, 2024EX2GSOU EXTENSION 2 GRANTED—
Oct 30, 2024EXT2SOU EXTENSION 2 FILED—
Oct 30, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 23, 2024EX1GSOU EXTENSION 1 GRANTED—
Apr 23, 2024EXT1SOU EXTENSION 1 FILED—
Apr 23, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 31, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 16, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 1, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 1, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 1, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 25, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 24, 2023GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Apr 24, 2023GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Apr 24, 2023EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Apr 24, 2023CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Apr 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 19, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 19, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 18, 2022DOCKASSIGNED TO EXAMINER—
Jan 18, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 14, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance